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INTRODUCTION
Measles outbreaks pose a continuing public health
problem in Africa and other developing nations of
the world1. Measles case fatality has been estimated to
be between 3 to 5% in developing countries and may
be as high as 10% during epidemics2. Despite the
efforts made at increasing immunization, measles
remains a leading cause of under-five mortality in
Africa3. There were about 139, 300 measles deaths
globally in 2011 representing nearly 380 deaths every
day or 15 deaths every hour4. Nigeria presently together
with other developing countries accounts for about
94% of global deaths caused by measles annually5.
In an effort to address the high mortality caused by
measles annually in Africa, countries in the World
Health Organization, (WHO) African region in 2001
adopted the accelerated measles control activities using
the measles mortality reduction strategies
recommended by the WHO and the United Nations
Children’s Fund (UNICEF). These strategies includes
; (1) achieving and maintaining e” 80% coverage with
routine measles vaccination of infants, (2) providing a
second dose of measles vaccine through supplemental
immunization activities (SIAs), (3) intensified measles
case-based surveillance with laboratory confirmation
and (4) improve measles case management during
outbreaks6-7. In Nigeria, literatures on measles outbreaks
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The Federal Ministry of  Health recommendations for
response during measles epidemics in Nigeria previously
focused on case management using antibiotics and Vitamin.
A supplements and did not include outbreak response
immunization (ORI) campaigns. However, with the revision
of the existing national technical guideline on measles case-
based surveillance and outbreak response in Nigeria in 2012
in line with the World Health Organization recommend-
ation on response to measles outbreak in measles mortality
reduction settings, there is a need to update members of
the Nigerian public health community on these revisions to
ensure appropriate implementation and compliance. This
article therefore seeks to provide clinicians and other public
health professionals in Nigeria with updates on recent
developments in measles case-based surveillance and
outbreak response in Nigeria
investigation  have shown that outbreaks of measles
annually are detected too late resulting in either no or
late response with minimal impact8. This could partly
be attributed to poor awareness among clinicians and
public health professionals of the measles case based
surveillance process and their role in immediate case
notification using the standard case definition. Also,
between epidemiological weeks 1 to 43 of 2013, about
six hundred and forty-three measles outbreaks were
confirmed in 83% of  the seven hundred and seventy-
four Local Government Areas (LGAs) in Nigeria with
outbreak response conducted in few of these LGAs
according to the revised national measles technical
guideline9. However, with the strengthening of the
measles case based surveillance in the country with
laboratory support to enhance early outbreak detection,
there is a need to update clinicians and public health
professionals on the measles case based surveillance
process, their roles and on the recent developments in
the conduct of measles outbreak response activities in
Nigeria to ensure proper implementation during
subsequent measles outbreaks in Nigeria.
Measles Case-based Surveillance in Nigeria
The success of prevention and control programmes
in reducing morbidity and mortality from vaccine
preventable diseases can only be measured if there is a
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reliable disease surveillance system in place10. In 2006,
measles case based surveillance became operational in
Nigeria using the resources and infrastructure of the
already established surveillance for Acute Flaccid
Paralysis3,7. The case-based surveillance system was put
in place to detect cases and outbreaks of  measles. It
involves immediate reporting and investigating any
suspected case of measles by clinicians using standard
case definition, evaluating immunization efforts and
predicting outbreaks through the identification of
geographical areas and age group at risk11. A suspected
measles case is any person with generalized
maculopapular rash and fever plus one of the
following: cough, coryza (runny nose) or conjunctivitis
or in any person in whom a physician suspect measles8.
For every suspected measles case, an individual case
investigation form (Fig. 1 and 2) should be completed
and a blood specimen collected and sent to the national
reference laboratory for testing for measles-specific
immunoglobulin M (IgM) antibody.  The designated
Local Government Area (LGA) Disease Surveillance
and Notification Officer (DSNO) at the LGA Primary
Health Care (PHC) Department is responsible for the
completion and transportation of the specimen6, 8. A
laboratory confirmed case of  measles is defined as a
suspected case with serological confirmation of
measles specific IgM antibody in a person who had
not received measles vaccination within 30days before
the specimen collection8. While a measles associated
death is defined as any death from illness in a confirmed
case of measles within 1month after the onset of rash8.
Fig. 1: Immediate case based reporting form8
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The national guideline on measles surveillance in Nigeria
defines a suspected outbreak as the occurrence of > 5
reported suspected cases of measles in a health facility
or district in a month and a confirmed outbreak of
measles as the occurrence of > 3 laboratory confirmed
measles cases in a health facility or district in one month8.
After an outbreak has been confirmed as measles,
subsequent cases are also investigated with serum
sample collected alongside nasopharyngeal swabs of
at least 5cases identified within 5days of onset of rash
for viral isolation8. All other new cases from which
serum specimens are not collected are linelisted and
are confirmed by epidemiological linkage.6, 8 In the
context of a measles outbreak, an epidemiologically
linked case is one without a blood specimen collected
and is linked in person, place and time to a laboratory
confirmed case.6, 8
It is paramount to note that the measles case-based
surveillance flow of  data in Nigeria requires that all
measles cases suspected by clinicians in all health facilities
must be reported immediately to the LGA DSNO
designated in the PHC department in each of the 774
LGAs in Nigeria using the reporting forms shown in
(Fig. 1 and 2) for investigation and prompt response.
While after reporting the first 5 cases other cases are
linelisted using the linelist form shown in (Fig. 3)8.
Fig. 2:Laboratory investigation form8
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Measles Outbreak Response in Nigeria: What’s
New?
Since the inception of  measles case-based surveillance
in Nigeria, several outbreaks have been detected. About
30, 194, 254 and 169 outbreaks were detected in 2006,
2007, 2008 and 2009 respectively.8, 12
The goals of conducting a measles outbreak response
vaccination is to reduce morbidity and mortality by
providing appropriate case management and
immunize children to limit the spread of the outbreak.
Also, outbreak response vaccination provides the
opportunity to identify and correct weaknesses in
the expanded use of a second opportunity for measles
immunization through nationwide mass vaccination
campaigns in high burden countries. This has resulted
in marked reductions in measles incidence associated
with large outbreaks, (2) endorsement of the
International Health Regulations in 2005 which
highlights the importance of timely detection and
response to events that are of potential international
public health concerns and (3) recent literatures on the
impacts of Outbreak Response Immunization (ORI)
during measles outbreaks which shows that  measles
epidemics in pre catch-up supplementary
immunization activities (SIAs) settings can last for 3-9
Fig. 3: Line list for reporting from health facility to LGA and for use during outbreaks8
immunization and surveillance activities in order to
monitor the changing epidemiology of  measles8, 13.
Antecedent to 2009, the national guideline on measles
outbreak response in Nigeria recommends only case
management with antibiotics and Vitamin A
supplementation. However, during the past years, three
important changes have occurred which includes; (1)
months providing adequate time to mount a focused
high quality campaign8,13-14. Findings  from previous
studies on measles outbreak investigation and response
vaccination have suggested that, (1) outbreaks of
measles can last for months in a limited geographical
area thereby allowing sufficient time to mount
immunization response, (2) outbreaks response
immunization was associated with reduced morbidity
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and spread of measles particularly if it was started
early and (3) a wide age range of children can  be
vaccinated and high coverage achieved in a measles
morbidity and mortality reduction settings15-19. Due to
these findings, the national guideline on measles
outbreak response in Nigeria was revised in 2012
accordance to WHO recommendation in 2009 for
the conduct of  an ORI during measles outbreaks.
However, the nature and extent of the vaccination
response should be based on the assessment of the
risk of spread, risk of severe outcome, capacity to
respond, background vaccination coverage of the
affected region, age distribution of cases, population
density and rate of migration in the affected area8, 13.
The aim of recommending the conduct of an ORI
campaign during measles outbreaks is to encourage
the principle of early detection of measles outbreak,
conduct thorough assessment and a rapid response
that also includes the expanded use of measles vaccine
alongside case management with antibiotics and
Vitamin A supplements8, 13.
When and How should an Appropriate ORI
Campaign be Conducted?
The national guideline for response to measles
outbreaks in Nigeria recommends two specific
strategies to control the outbreak: “selective” and “non-
selective” Outbreak Response Immunization (ORI)8.
Selective ORI includes providing measles vaccination
through routine service sites for all unvaccinated
children aged 6-59months or an age group based on
the measles epidemiology15. “Selective” ORI is
recommended as soon as an outbreak of measles is
suspected (occurrence of >5 cases of reported
suspected cases of measles in a health facility or district
in 1month). During “selective” ORI, the following
activities are recommended to be conducted; (1)
inform the communities affected about the suspected
outbreak with instruction provided, (2) vaccinate all
children presenting at the health facilities and
immunization post 6months to 5years without a history
of measles vaccination (3) re-vaccinate all children
receiving measles vaccine before 9months, (4) re-
enforce the conduct of  routine immunization services
to rapidly identify priority areas within the affected
district to correct programme weakness (Fig. 4)8.
“Non-selective” ORI is recommended as soon as a
measles outbreak is confirmed (occurrence of > 3
laboratory confirmed case in a health facility or district
in 1month)8. “Non-selective” ORI refers to a mass
vaccination campaign that targets all children in a
specific age group and geographical area8. However,
before the decision to conduct a “non-selective” ORI
is reached there is a need to conduct a risk assessment
to determine if  the risk of  a large outbreak is high,
availability of the capacity to carry out a high quality
large scale immunization campaign with respect to staff
strength, financial resources and availability of vaccine
and other supplies within the timescale necessary8. The
Fig. 4 : Flowchart for suspected measles outbreak response13
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risk assessment should take into consideration; the
susceptibility of the population, potential for spread
both in the affected and neighbouring areas, morbidity
and mortality.8 Also, if  the outcome of  the risk
assessment does not indicate a need for a “non-
selective” ORI, then “selective” ORI is recommended
as outline above and the number of reported cases
closely followed to monitor the progression of the
outbreak. Flowchart for responding to a confirmed
measles outbreak is illustrated in Figure 5 below. For
“non-selective” to be effectively carried out, the timing,
the target age group and area for vaccination should
be defined. Also, an accelerated microplanning exercise
should be performed to determine the bundle vaccine
logistics, staffing and communications need for the
campaign. Furthermore, the current national guideline
for conducting mass measles vaccination campaigns
should be used to guide the exercise8.
CONCLUSION
The decision to conduct either a “selective” or “non-
selective” outbreak response immunization during
measles outbreaks is taken by the Outbreak
Coordination Committee which is expected to be at
all the three tiers of government (Local Government
Areas, State and Federal level) with the target group
for the exercise chosen based on the epidemiology of
the outbreak, geographical distribution of cases and
age specific attack rates. Also, high quality surveillance
data and population figures are needed to accurately
determine the target group. It is also important to note
that outbreak response immunization campaigns are
distinct from preventive supplementary immunization
activities that targets the whole country and states and
therefore it should be limited in scale. High rate of
compliance and best practice according to these
revisions in the measles case based surveillance and
outbreak response are encouraged among public health
professionals in Nigeria during subsequent measles
outbreaks in Nigeria.
Figure 5: Flowchart for responding to a confirmed measles outbreak
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